To date most of these imaging procedures have been performed by vets within the group’s small animal first opinion veterinary practices.
The company says its Foundations in Diagnostic Imaging for Nurses training is designed to give its nurses more clinical stature in first opinion practice.
The programme will teach nurses the workings of an x-ray machine, common X-ray positions and contrast material.
It will also cover the principles of CT and MRI, showing how to set up and operate each piece of equipment, and how to support patients through these imaging procedures.
Finally, the course will provide the training nurses need to be able to perform ultrasounds within the current RCVS legal frameworks.
CVS says it believes this is a first in the veterinary profession
Tara Ryan, Chief Veterinary Nursing Officer at CVS said: “Imaging is a brand new area that we are starting to delegate to our nurses.
"Having heavily invested in our small animal first opinion practices over the last decade, we have a wide range of imaging equipment at many of our sites.
“Excitingly, this programme will open up the ability for nurses to start to contribute more information - to help vets identify and diagnose conditions and diseases in patients.
"It is another big step that we are taking to empower our brilliant nurses and to enable them to make a great clinical contribution towards the care of our patients – and to be the nurses they want to be.”
CVS is prioritising the consulting room and Schedule 3 delegated tasks as important areas for improving what it calls 'nurse optimisation'.
The company recognises that 'buy in' from veterinary surgeons is vital to the success of its efforts to optimise the role of its nurses, and the group has also published guidelines to provide clarity around effective delegation under Schedule 3.
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
During a welcome reception, leaders and representatives of the veterinary profession were given tours of the facility and shown the advanced surgical training and ultrasound equipment available.
The wet-lab is equipped with 13 electrically-adjustable surgical tables, each with their own operating light and an audio-visual (a/v) system connecting them to the lecturer. The a/v system enables the lecturer to carry out demonstrations of procedures and to provide individual or group guidance to delegates practising surgical and other practical techniques.
Delegates are able to use the latest surgical and diagnostic equipment, including IM3 dental equipment, Logic E ultrasound machines and new surgical instrumentation for a range of orthopaedic and soft tissue procedures.
Improve's Managing Director, David Babington MRCVS, said: "Newly qualified vets have a huge need for additional training in practical skills and this demand extends into their ongoing professional life as new techniques are developed and existing ones refined.
"We already offer practical training facilities to delegates attending our training programmes at our HQ in Swindon but wanted to make it easier for vets and nurses in the north of the UK to access these facilities. This new 'wet-lab' offers an ideal training environment for our delegates to accelerate their learning and take new skills back to their practice."
He added: "Learning new techniques, whether surgical or diagnostic, is a proven way to boost practice profitability because it reduces the need to refer more complex cases. We hear from many of those who have trained with us that their increased skillset has enhanced their job satisfaction and increased the volume of cases they treat. In many cases, the training has paid for itself many times over. We are excited at the prospect of helping even more veterinary professionals to advance their skills."
The new GPCert programme, led by course director Owen Davies MA VetMB MVetMed MANZCVS (Small Animal Medicine) DipACVIM (Oncology) (pictured right), consists of 12 modules covering key clinical subjects in veterinary oncology delivered over 14 months.
Each module consists of nine lessons, two case studies, course notes and weekly summary videos.
Lessons are supported by notes and videos, quizzes and a forum tutored by leading specialists.
Owen said: “Half of all canine cancers are treatable if caught early enough and new treatments are continuously being researched.
"The programme will guide delegates through the latest knowledge in state-of-the-art, compassionate cancer care for animals, helping them to provide safe and comprehensive diagnostics and treatments.”
For more information, visit: https://www.improveinternational.com/uk/course/oncology-online-learning/
The impact of the College's research on society was similarly highly-ranked, with 83% being scored 4*, and 7.5 of the 9 impact case studies submitted found to have “outstanding reach and significance”.
Additionally, there has been a 54% increase in the number of full time equivalent academic staff submitted since the last assessment – establishing the RVC as the largest veterinary research institution in the country.
The impact case studies submitted by the RVC covered a range of research areas, including those which advance clinical practice; protect public health by enhancing food safety; inform World Health Organisation and the Food and Agriculture Organisation policy on the control of disease afflicting some of poorest people in the world; and tackle antimicrobial resistance through innovations in drug delivery.
The College says the results also highlight its holistic and transdisciplinary approach to research, with researchers, teachers, clinicians and pathologists working collaboratively to ensure ‘real world’ impact and advances in clinical practice.
Professor Jonathan Elliott, Professor of Veterinary Clinical Pharmacology at the RVC, said: “REF 2021 has recognised the outstanding reach and significance of the impact of our research which is so pleasing to see.
"I know all my academic colleagues are motivated to innovate in order to make a difference to lives of people and those of the animals they keep.
"Our submission truly reflects the breadth of scholarship at the RVC which generates the new knowledge we teach our students, the high quality of which has been endorsed by this external review.”
Vita Referrals has been set up by Rob Quinn, an RCVS and EBVS Specialist in Small Animal Surgery, and Nick Blackburn and Stuart Cooke, both RCVS Advanced Practitioners in Small Animal Surgery.
They say that their aim is to ensure every pet owner has access to reasonably priced surgical care.
To that end, the clinic lists fixed costs for all of its major surgical specialities on its website, where it says clients should notice a significant reduction compared to other providers.
It also offers a 12-month post-surgical complications warranty.
Rob said: “Many pet-owners are unaware that there are three major companies which own the vast majority of veterinary practices in the UK.
"That is not necessarily of benefit to those using the services, as prices can rise when competition is low.
"Myself, Nick and Stuart felt very strongly that there was a different way to do things.
“No one becomes a vet to see animals suffer or pet-owners struggle to make tough financial decisions.
"We knew it was possible to offer a top quality service, with the best facilities and equipment available, whilst also keeping prices at a realistic level – and that is where the vision for Vita Referrals came from.
"We also wanted the freedom to offer collaborative decision-making, the removal of complex forms and bureaucracy and what we believe is an industry-leading 12-month complications guarantee on routine surgeries.
"It’s time there was more disruption and competition in the sector – and that will, ultimately, only be a good thing for pets, owners and vets.”
www.vitareferrals.co.uk
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
The Veterinary Hospital and Surgery acquired the Magdalen Arms in late 2014 and started work on the conversion of the listed building in March 2015, with particular care needed to preserve original features including its Dutch gables and the falcon logo of local brewery Lacon’s, which is incorporated into the brick work.
The new hospital was officially opened at the end of February, with the Mayor of Great Yarmouth, Malcolm Bird, and local 2012 Paralympic gold medallist Jessica-Jane Applegate unveiling the plaque. More than 1,000 local people came to have a look round, many bringing their canine friends.
Clinical Director Elissa Norman said: "In recent years we had outgrown our original surgery and it started to become difficult to offer the level of service we wanted to within the space we had.
"We knew that the Magdalen Arms, in addition to being a well-known local landmark, offered all the space we needed, a central location and plenty of parking. The structure of the building made the conversion quite complex but the final result is beyond our expectations and we can’t wait to see the reaction of our clients when they bring their pets to us for the first time."
"We now have staff on site with patients 24 hours a day, 365 days of the year, plenty of parking and we can offer full access for disabled clients all of which were a priority for us. The reception area is spacious and inviting, the consult rooms are well equipped and the new cat ward will create a less stressful environment for our feline patients.
"Watching this much-loved building take shape as a brand-new hospital with all the facilities we need for our patients, their owners and our staff has been special and I’m looking forward to helping it take on a different role within the community. While the building work is now finished, we have lots of plans to develop the service we offer further over the next few months."
"We are grateful to the Mayor Malcolm Bird and to Jessica-Jane for helping us celebrate the opening of the hospital and it was great to welcome so many local people and show them around as they have been so supportive during the conversion. It is clear that the building holds a strong place in many of their memories but that they are as excited as we are to see the amazing transformation that has taken place. We look forward to serving them and caring for their pets in the years ahead."
Speakers include Dr Ian Stroud, founder and veterinary director of Pet People, an independent small animal practice in Richmond, South West London, Jack Peploe, a veterinary IT expert and Certified Ethical Hacker, and Ciaran Milford, ezyVet’s EMEA sales manager, who has worked with every type of veterinary practice, from aspiring independents right through to established universities and corporate groups.
Lance Rice, creative director at ezyVet, who will moderate the webinar, said: “This webinar is for anyone who feels as though they’ve gone as far as they can in a senior vet or clinic director role, and thinks it might be time to follow their dream of opening their own practice.
“Our speakers are all vastly experienced and ideally positioned to explain what makes a successful launch, as well as the key mistakes and common traps that new owners fall into.
"Ian has a unique understanding of the challenges and opportunities involved with starting a veterinary practice.
"Jack is an expert in helping practices leverage technology to save time, whilst delivering exceptional patient care and bolstering their security posture.
"Ciaran is passionate about helping practices find the right solutions for their needs and business goals."
To register, visit: https://www.ezyvet.com/webinar/starting-a-vet-practice-uk
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
The Royal College of Veterinary Surgeons Charitable Trust has awarded five new bursaries in its latest grants round.
Two student bursaries were for UK veterinary undergraduates to attend the British Science Festival in Aberdeen from 4-9 September 2012. The bursary winners were Liv Nathan (pictured on right), a third-year veterinary student at the Royal Dick School of Veterinary Studies, and Alahel Mahdmina, a second-year veterinary student at the Royal Veterinary College.
Liv said: "I am very enthusiastic about providing real-life context to science and giving people a space to consider issues arising around science."
The students were required to use their observations and experiences to help the Trust develop future outreach activities to inform and inspire public audiences about veterinary clinical practice and research. Their bursary packages covered all their attendance expenses over the four-day event. One of their achievements was to film an interview with Dr Maggie Aderin-Pockock MBE, a space scientist (pictured on left). Both students will be reporting back in full to the RCVS Charitable Trust with their ideas at the end of October.
Two further bursaries were given to attend a joint symposium on antimicrobial resistance (AMR): 'Antimicrobial Resistance in Human and Veterinary Medicine - One Health, One Problem' to be held at the Royal College of Physicians, London, on Tuesday 2 October 2012.
One winner was Cahir King, a practitioner from Downe Veterinary Clinic in County Down, Northern Ireland. He said: "It will be a privilege to attend a symposium at which so many experts in their field will be speaking. Any vet who has worked on farms will be more than familiar with bugs that are resistant to antibiotic treatment."
The other winner was James Swann, a Junior Clinical Training Scholar (Small Animal) at the Royal Veterinary College. James said: "I am particularly interested in the application of clinical audit in practice to assess problems like AMR, and design effective strategies to deal with them. I believe it should be possible to provide simple audit kits for practices to download and implement, removing much of the inertia that prevents such ideas from being initiated."
The bursary winners will be offered free delegate passes, including lunch, worth £90, and travel expenses.
The final bursary is to attend the Veterinary Biomedical and Pharma Sciences (VBMPS) Congress on 15-16 October, in Birmingham.
The winning entry was from Alexander Stoll, a final-year student at the Royal Veterinary College, who acted as the Royal Veterinary College and UK student ambassador to the European Commission for the 'One Health' message. The Trust was impressed with Alexander's enthusiasm and active engagement in subjects related to One Health. He is a member of the Royal Society for Public Health and a member of the Society of Biology.
Alexander said: "I hope to be inspired to enter a cross-disciplinary career path and also to communicate the potential of a One Health approach, inspired by this congress."
Alexander won a package that includes entry to the conference and admission to all scientific sessions, worth £175, as well as transport costs and overnight food and accommodation.
A Market Harborough-based practice - Town & Country Veterinary Centre - has announced that it is entering a team into a 10km obstacle course race so gruelling it is called 'The Suffering'.
The Suffering takes place in the grounds of Rockingham Castle, Leicestershire, on Saturday 12 March 2016. It includes more than 25 water, mud and rope-based obstacles.
The Town & Country team, which includes vets, nurses, students and receptionists, hopes to raise £1,000 for Vets for Change, which is fundraising to vaccinate dogs in Africa against rabies.
Michael Lander MRCVS said: "We are big supporters of the work of Vets for Change which is currently fundraising for its next mass vaccination programme in South Africa. The race does sound gruelling and I have done no training as yet although some of my colleagues have been hitting the gym for the past couple of months. We will all pull together on the big day and getting everyone round the course is our goal.
"We'd be very grateful for donations to help us reach our target for Vets for Change which does such fantastic work and have set up a just giving page at https://crowdfunding.justgiving.com/townandcountry-veterinarycentre."
The team members are: Sarah Kay Robinson (Receptionist), Chloe Brown (Receptionist), Zara Lander (VN), Katy Kirkham (VN), Kathleen Gamble (VN), Grace Costall (Student VN), Kate Bodley (Small Animal Vet), Michael Lander (Small Animal Vet), Lucinda Ticehurst (Equine Vet).
The hands-on course, which is worth 7 CPD hours, has been organised by Dr Nicola M Parry, Recognised Specialist in Pathology at the University of Surrey School of Veterinary Medicine. It will combine lectures, practicals, and a Q&A session to enable delegates to carry out a post-mortem, identify common (and not so common) pathologies, and draw conclusions about the cause of death.
The morning lectures will provide an overview of techniques that focus on how to approach the post-mortem examination of the adult horse and the foetus/foal, as well as how to examine the placenta. Potential findings will be discussed as well as some pitfalls to avoid during the post-mortem examination, and how to optimise sample submission. The lectures will be recorded, enabling sessions to be reviewed later.
Delegates will spend the afternoon in the post-mortem room, examining macroscopic specimens and learning practical approaches to a post-mortem examination in the field, and the collection of key specimens. The day will close with a Q&A session.
Speakers Dr Fabio Del Piero from the Louisiana State University and Dr Marvin J Firth from the University of Surrey will help delegates to:
Sarah Gaspar, the Learning Manager at BEVA said: “If you have ever been called out to a dead horse to find a distraught owner and not been sure how to identify the cause, this course is for you. We can’t remember any course ever having been run on this topic in the UK before; it is likely to be very popular so be quick to book.”
To find out more and to book click here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1582
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
The company points to data from the Animal Poison Control Center in the US which showed that in 2022, recreational drugs, including marijuana-based drugs, hallucinogenic mushrooms and cocaine made the list of top ten reasons for animals needing its help, knocking gardening products into 11th place.
In addition, the APCC reports a nearly 300% increase in calls about potential marijuana ingestion over the past five years
With this in mind, TVM has developed guidelines to support vets with these cases, both in terms of treatment options and tips on how to discuss the issue with clients and glean the information needed to help with the diagnosis and treat the animal.
TVM has also launched its new ‘Seasonal Suspects’ board kits to help vets educate pet owners on the common Christmas hazards commonly found around the house at this time of year.
The eye-catching waiting room display, which shows veterinary staff as seasonal superheroes, covers the dangers posed by items such as alcohol, batteries, plants and nuts, and advises pet owners on the necessary action needed should their pet digest any toxic substance.
TVM will also be sharing ‘Seasonal Suspects’ posts on its Facebook page for veterinary staff to share with their followers over Christmas.
For more information, email help@tvm-uk.com, call 0800 0385868 or contact your local Territory Manager.
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
Set up in 2012, the programme was developed to raise the standards of care and welfare of cats in the veterinary clinic, and to provide veterinary surgeons with practical solutions to problems that they face when dealing with their feline patients. The programme is also designed to boost business by strengthening the bond between the clinic and its feline clients.
Four years later, with 732 practices accredited worldwide (369 in the UK) and a further 1,000 US practices accredited under the American Association of Feline Practitioners scheme licensed from ISFM, the programme has become a well-recognised global standard in feline veterinary care. Last October, it was the winner of the 2016 Veterinary Record Innovation Award.
ISFM says it has now signed six new commercial partners for the scheme: Boehringer Ingelheim, Ceva Animal Health, Elanco, Idexx Laboratories, Merial and Royal Canin, and will be working with these partners to expand the programme further.
Dr Andy Sparkes, Veterinary Director of International Cat Care, ISFM’s parent charity, said: We are delighted to see how many clinics around the world have focused on becoming cat friendly and we can only expect this to grow again in 2017 with our new partners on board. We are looking forward to a very cat friendly 2017!"
Clinics interested in joining the scheme should visit: www.catfriendlyclinic.org for further information, including an extensive library of photographs from already-accredited clinics to provide inspiration and ideas.
NDSR’s director of neurology Rodolfo Capello said: "This technology is one of the most advanced in medicine and helps to surgically remove tumours while also reducing the tissue damage to vital structures.
"The accuracy and control of the system offers us greater versatility and precision, and minimises invasive manoeuvres during both soft and hard tissue dissections.
"Surgeons can therefore be extremely confident of accurate tumour excision with reduced blood vessel and tissue damage which will all help increase and improve the outcome of our surgeries.
"We’ll be using the ultrasonic surgical aspirator for the removal of tumours in the brain, liver and to cut through bone where necessary. It will be a great asset."
For more information, visit: www.ndsr.co.uk
The publication of the guide follows a study of vet professionals published in the Journal of Feline Medicine and Surgery which revealed that the main barriers to blood pressure measurement are a lack of time (72.8%) and situational hypertension (92%)1.
Vet professionals also thought the main barrier for owners was cost (80%) whilst the least problematic aspect is the longer consultation needed to accommodate a blood pressure measurement (48.8%).
The guide has been written to address these concerns and empower vet nurses to run nurse-led clinics for older pets.
Written by RVN, Beth Kirwan, the guide provides information on the benefits of vet nurse-led senior pet clinics, which can either be free or paid, together with hints and tips on how to get started and promotion.
The guide also covers the importance of a senior health-check questionnaire, tips on preparing and setting up a clinic, a 10-point health check providing guidance on what should be covered and information on additional senior pet tests that can be carried out, such as blood pressure checks for senior cats aged seven years or older to help identify feline hypertension.
Beth said: "I was really excited to be asked by Ceva to create this resource for veterinary nurses and grateful for the opportunity to share my experiences and knowledge.
"I have been a nurse for over 22 years, and I am passionate about making our nurses feel valued in practice.
"Nurse clinics are a really good way to do this, but I feel that setting up a senior nurse clinic service in a practice creates so much value in many ways and for every member of the practice, from the receptionists to the vets.
"Our RVNs are the stars of the show with senior nurse clinics; they bring so much experience, care and compassion and are a great reflection of our practice values.
"They often have the time that the vets don't have and will go home knowing they made a difference to a pet and an owner, or a family.
"Veterinary nurses can help identify disease early, support the owners with home adaptations or new medicine regimes.
"They can also educate the clients in senior and super senior care as our pets are living longer and provide quality of life and end of life support.
"The benefits are huge; as well as a financial benefit support like this will bond clients to a practice for life.
"We are all businesses, but we need to be caring businesses.
"I hope the guide provides inspiration to many nurses and empowers them to set up a new service or helps them to improve their current one."
Dr Sarah Caney, RCVS recognised Specialist in Feline Medicine who led the study said: “Our recent survey had more VN participants than vets, showing just how enthusiastic and engaged nurses are when it comes to assessing blood pressure in cats.
"Owners very much appreciate nurse clinics and I’m delighted to hear that there is a new senior pet clinics guide to support nurses in setting up and running successful clinics.”
https://easethepressure.co.uk/feline-senior-health-clinics
Reference
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
Boehringer Ingelheim Vetmedica has re-launched its Vetmedin website: www.vetmedin.co.uk.
Boehringer says the new site has been designed as a resource for veterinary professionals to help educate clients with dogs suffering from congestive heart failure. It includes an animation about heart disease, together with hints, tips and videos covering exercise, diet, treatment and how to monitor the condition.
To support the relaunch of www.vetmedin.co.uk, Boehringer is offering veterinary professionals a £25 money-off voucher towards the NEW edition BSAVA Manual of Canine and Feline Cardiorespiratory Medicine. To qualify for the voucher you need to recommend www.vetmedin.co.uk to two separate dog owners being prescribed Vetmedin for congestive heart failure in their pets and then record any feedback at their next appointment. Faxback forms on which to record this feedback are being sent out to all vets around Valentine's Day but extra copies are available from Boehringer direct.
The company says a Vetmedin eCPD professional resource will also be launching on the new site later in the year, featuring an online radiograph viewer, technical dossiers and information on published studies such as QUEST.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
MSD Animal Health has launched a new Chronogest CR pack for practices starting a dialogue with sheep producer clients about planned breeding for 2013 lamb sales, and is offering a free applicator with every four packs purchased.
The Chronogest CR intra-vaginal sponges, impregnated with 20mg of cronolone (flugestone acetate) synthetic hormone, are now available in foil wrapped packs of 25. The packs protect the sponges from light and moisture.
MSD is reminding practitioners that sponging programmes must be planned at least six weeks in advance of mating, with PMSG-Intervet injections essential at sponge removal.
The new packs of 25 will be available when existing 25, 50 and 100 pack sizes sell out.
Further information on planned breeding - including newsletter copy and sheep producer advisory materials - is available from the MSD Animal Health veterinary support group (VSG) on 01908 685685 or via emailing vet-support.uk@merck.com